Fenbendazole
Therapeutic Category:
Anthelmintic
Binds to β-tubulin, inhibiting microtubule formation and glucose uptake in parasites, leading to energy depletion and death
Primary Use:
Treatment of gastrointestinal worms and lungworms
Broad-spectrum activity against nematodes and some cestodes
Target Species:
Equine, field animals, milking animals
Status:
Commercial
Monograph:
IP, BP, EP
Regulatory Status:
DMF, CEP FILED
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.